Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States.
Saved in:
| Title: | Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States. |
|---|---|
| Authors: | Chien A; Medtronic Diabetes, Northridge, California, USA., Shin JJ; Medtronic Diabetes, Northridge, California, USA., Liu M; Medtronic Diabetes, Northridge, California, USA., Arrieta A; Medtronic Bakken Research Center, Maastricht, The Netherlands., Cordero TL; Medtronic Diabetes, Northridge, California, USA., Swensen AR; Medtronic Diabetes, Northridge, California, USA., Vigersky RA; Medtronic Diabetes, Northridge, California, USA. |
| Source: | Diabetes technology & therapeutics [Diabetes Technol Ther] 2025 Dec; Vol. 27 (12), pp. 989-996. Date of Electronic Publication: 2025 Sep 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-8593 |
|---|---|
| DOI: | 10.1177/15209156251376654 |
